SABS · SAB Biotherapeutics, Inc.
$3.45
+0.01 (+0.29%)
At close · Jul 28
Market Cap
$263.80M
Shares
76.46M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-29 | 36,033 | $3.80 | $136,925 |
| 2026-06-25 | 30,000 | $3.84 | $115,200 |
| 2026-06-23 | 26,452 | $3.93 | $103,956 |
| 2026-06-22 | 13,671 | $4.00 | $54,684 |
| 2026-06-18 | 19,534 | $3.86 | $75,401 |
| 2026-06-16 | 1,243,286 | $3.90 | $4,848,815 |
| 2026-06-09 | 1,568 | $3.40 | $5,331 |
| 2026-06-05 | 22 | $3.47 | $76 |
| 2026-06-02 | 1,889 | $3.44 | $6,498 |
| 2026-06-01 | 7,846 | $3.60 | $28,246 |
| 2026-05-28 | 406 | $3.60 | $1,462 |
| 2026-05-22 | 37,549 | $3.81 | $143,062 |
| 2026-05-21 | 50,000 | $3.68 | $184,000 |
| 2026-05-20 | 99,897 | $3.55 | $354,634 |
| 2026-05-19 | 105,639 | $3.56 | $376,075 |
| 2026-05-18 | 49,897 | $3.70 | $184,619 |
| 2026-05-15 | 99,998 | $3.89 | $388,992 |
| 2026-05-14 | 50,000 | $3.96 | $198,000 |
| 2026-05-13 | 60,737 | $3.62 | $219,868 |
| 2026-05-12 | 116,099 | $3.72 | $431,888 |
| 2026-05-11 | 74,998 | $4.11 | $308,242 |
| 2026-05-08 | 250,000 | $4.09 | $1,022,500 |
| 2026-05-07 | 119,082 | $3.80 | $452,512 |
| 2026-05-06 | 227,206 | $3.68 | $836,118 |
| 2026-05-05 | 143,778 | $3.69 | $530,541 |
| 2026-05-04 | 258,112 | $3.47 | $895,649 |
| 2026-05-01 | 102,932 | $3.74 | $384,966 |
| 2026-04-30 | 74,351 | $3.48 | $258,741 |
| 2026-04-29 | 99,053 | $3.53 | $349,657 |
Showing 1–29 of 29 settlements